2026 NPPES data Medical Oncology Physician NPI 1144205295 M.D.
Verify on CMS →

DEEPIKA WALI, M.D.

Medical Oncology Physician in KLAMATH FALLS, Oregon. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 180 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

DEEPIKA WALI, M.D. filed 1,227 Medicare Part D claims in 2023 as a Medical Oncology Physician in KLAMATH FALLS, Oregon, prescribing 93% generic.

1K
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEEPIKA WALI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,227 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

DEEPIKA WALI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEEPIKA WALI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 12/13/2005

NPI 1144205295

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

1,227 78% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Oregon

How Medical Oncology Physician compares to other specialties among Oregon providers

Oregon providers

Medical Oncology Physician share within Oregon

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Oregon

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEEPIKA WALI, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 2610 UHRMANN RD, KLAMATH FALLS, OR, 97601, with a listed phone of (541) 274-4171. NPI 1144205295 was issued on 12/13/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WALI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,227 prescription claims written by this provider, covering 180 Medicare beneficiaries and totaling roughly $636K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 8.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2610 UHRMANN RD
KLAMATH FALLS, OR 97601

Provider Details

NPI 1144205295
Specialty Medical Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 12/13/2005

Hospital and facility affiliations

Facilities where DEEPIKA WALI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SKY LAKES MEDICAL CENTER INC
KLAMATH FALLS, OR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Generic-heavy

DEEPIKA WALI, M.D. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 1,227 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,227
Total Claims
$636K
Total Drug Cost
180
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,565
Total Day Supply
39,655
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$493K
Generic Drug Cost
$143K
Opioid Claims
102 (8.3% rate)
Antibiotic Claims
48

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.93
Gender Split
57% female / 43% male
Age Distribution
<65: 24, 65-74: 78, 75-84: 60, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DEEPIKA WALI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
100
Potassium Chloride
57
Famotidine
54
Prednisone
51
Dexamethasone
50
Ondansetron Odt
Ondansetron
48
Prochlorperazine Maleate
41
Trazodone Hcl
38
Lorazepam
35
Acyclovir
34

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How DEEPIKA WALI, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

DEEPIKA WALI, M.D.'s 1,227 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Oregon

Other clinicians with the same primary specialty enrolled in Oregon, drawn from the same CMS NPPES roster as WALI.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEEPIKA WALI, M.D.'s specialty?
DEEPIKA WALI, M.D. specializes in Medical Oncology Physician and practices in KLAMATH FALLS, Oregon. Credentials: M.D..
How much does DEEPIKA WALI, M.D. prescribe under Medicare Part D?
In 2023, DEEPIKA WALI, M.D. wrote 1,227 Medicare Part D claims totaling $636K in drug costs for 180 beneficiaries.
Where is DEEPIKA WALI, M.D. located?
DEEPIKA WALI, M.D. is located at 2610 UHRMANN RD, KLAMATH FALLS, OR, 97601. Phone: (541) 274-4171.
What is DEEPIKA WALI, M.D.'s NPI number?
DEEPIKA WALI, M.D.'s National Provider Identifier (NPI) is 1144205295, issued on 12/13/2005.
Does DEEPIKA WALI, M.D. prescribe more brand-name or generic drugs?
DEEPIKA WALI, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $493K in brand drug costs.
Does DEEPIKA WALI, M.D. prescribe opioids?
Yes, DEEPIKA WALI, M.D. had 102 opioid claims in 2023 with an opioid prescribing rate of 8.3%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does DEEPIKA WALI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DEEPIKA WALI, M.D.'s most frequently prescribed drugs include Letrozole, Potassium Chloride, Famotidine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEEPIKA WALI, M.D. accept Medicare?
DEEPIKA WALI, M.D. appears in CMS Medicare data with 1,227 Part D claims and 180 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEEPIKA WALI, M.D.'s credentials?
DEEPIKA WALI, M.D.'s NPI is 1144205295 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology